Search

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Patrick Chinnery appointed as MRC Clinical Director. ... Professor Chinnery moved to Cambridge in 2015 where he became Head of Department for Clinical Neurosciences.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Treatment Studies. Please see below for further details on our studies that are designed to examine possible treatments. ... Please click text below to find out more. 2024 University of Cambridge.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Honour awarded to Professor Maria Grazia Spillantini. ... Professor Spillantini is a lecturer in molecular neurology at the University of Cambridge, where she researches the mechanisms that cause

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Measuring Studies. Please see below for further details on our studies that aim to measure disease burden. ... Please click text below to find out more. 2024 University of Cambridge.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Alemtuzumab (Lemtrada). The history of alemtuzumab use in multiple sclerosis. ... The University of Cambridge has made a video on the history of alemtuzumab and published an article covering similar ground

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Chloe Seikus. Chloe Seikus. Chloe Seikus joined the Department of Clinical Neurosciences as a research assistant in 2020, where she was responsible for recruiting participants to ... the groups’ research

23 Feb 2024: My research interests have focused on how different brain regions communicate, neural plasticity, neural networks, and how abnormalities in these mechanisms can result in pathology. ... In October 2019, I joined Dr Deborah Vickers’ lab, University of

23 Feb 2024: Department of Clinical Neurosciences. Featured news. AI could detect dementia years before symptoms appear. ... Filed Under: Featured news.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. NHS England algorithm published. 16th September 2018. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: Department of Clinical Neurosciences. Events. Cambridge Philosophical Society Lecture Monday 27th February. ... 23rd February 2023. Professor Patrick Chinnery will be delivering a lecture to the Cambridge Philosophical Society on Monday 27th February.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. ‘Biohybrid’ device could restore function in paralysed limbs. ... Filed Under: Featured news.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. EMA lifts restriction on alemtuzumab use. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. ... Filed Under:Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: Neurotrauma research within Neurosurgery and Anaesthesia aim to improve the understanding of the mechanisms of brain injury to develop novel treatment strategies that improving the clinical outcome. ... We are strongly committed to improve outcomes in

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Understanding Studies. Please see below for further details on our studies that aim to further understanding of mitochondrial and neurodegenerative diseases. ... Please click text below to find out more.

23 Feb 2024: Horvath Laboratory. Denisa Hathazi. Denisa Hathazi. PhD. Denisa is a research associate in in the Horvath group since 2019. ... Her current research project studies hereditary mitochondria translational defects affecting muscle and the nervous system.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Non-disabling relapses count too! 6th March 2023. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Cambridge Centre for Myelin Repair. Alasdair Coles leads the Cambridge Centre for Myelin Repair, alongside Prof. ... CCMR is a multi-PI coordinated programme that brings together the diverse but

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. FDA warning: stroke after alemtuzumab. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: Gates US: 11. th. October 2023 (now closed). Postgraduate Funding Competition (all other funders including Gates Cambridge): 5. ... Identify the research project you wish to apply for by reviewing the list of available research projects..

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Alemtuzumab rarely causes sarcoidosis. 17th October 2018. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. ‘Digital mask’ could protect patients’ privacy in medical records. ... shared. Filed Under: Featured news.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Apathy not depression helps to predict dementia. ... Lead author, Jonathan Tay, from Cambridge’s Department of Clinical Neurosciences said: “There has been a lot of conflicting research on the

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. CCMR2 Trial will start in March 2022. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Antibodies in neurological disease. Antibodies are usually part of the body’s defense against infections and cancer, but in autoimmune diseases they can mistakenly attack healthy ... Funding: British

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Ageing in Multiple Sclerosis (McMurran Group). ... Professor of Clinical Neuroimmunology. Alasdair has worked in Cambridge since 1994, when he started his PhD with Alastair Compston.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. CCMR One (Bexarotene) Trial fully recruited. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Gender bias in clinical trials in MS. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: The Centre was formed to bring Cambridge scientists working across the many fields of modern neuroscience together in cross-disciplinary research efforts directed at preventing or repairing neurodegeneration in injury and ... Laboratory-based research

23 Feb 2024: Department of Clinical Neurosciences. Featured news. New research group to help discoveries benefit patients. ... Cambridgeshire and Peterborough NHS Foundation Trust has partnered with the University of Cambridge to set up the Gnodde Goldman Sachs

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Optic neuropathy patient organisations. UK LHON Society. ... Autosomal Dominant Optic Atrophy (ADOA) Association. Autosomal Dominant Optic Atrophy (ADOA) Association is a charity dedicated to raising

23 Feb 2024: Department of Clinical Neurosciences. Featured news. The neuroscientist hoping to slow down dementia and speed up Darwin. ... Jess’ research has led to the launch of a clinical trial, which is testing a new treatment to slow down the progression of

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Mitochondrial disease patient organisations. Lily Foundation. ... To find out more information, including other current research, please click here to be directed to their webpage.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Inflatable, shape-changing spinal implants could help treat severe pain. ... Filed Under: Featured news.

23 Feb 2024: Wolfson Brain Imaging Centre (WBIC). The Wolfson Brain Imaging Centre (WBIC) is a major research facility in the Unversity of Cambridge, dedicated to bringing the latest imaging research imaging protocols to ... As a dedicated research facility on the

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Ultra-powerful brain scanners offer hope for Parkinson’s disease patients. ... Filed Under: Featured news.

23 Feb 2024: This is the approach taken by neurotrauma research at Cambridge, which spans the Divisions of Neurosurgery, led by Professor Peter Hutchinson, and Anaesthesia, led by Professor David Menon. ... Neurosurgery 2015; 76(1):67-80. This work is supported by

23 Feb 2024: 2024 University of Cambridge.

23 Feb 2024: SOUND Laboratory. Nicholas Haywood. Nick is a Research Associate working on an MRC-funded project developing electrophysiology measures of brain activity to optimise cochlear implant outcomes. ... Contact. Contact Us. 2024 University of Cambridge.

23 Feb 2024: 13th May 2022. The research, from the University of Cambridge, Wellcome Sanger Institute, and collaborators, has created an open-access atlas of the immune cells in the human body and focuses ... Dr Joanne Jones, co-senior author from the Department of

23 Feb 2024: Horvath Laboratory. Natalia Malig. Natalia Malig. Research Assistant. Natalia is a Research Assistant in the group of prof. ... Hannah Monyer at DKFZ. Ever since, she has a strong interest in the topic and aspires to continue research as an MPhil student.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Scientists identify first genetic marker for MS severity. ... Studying the genetics of multiple sclerosis has been a major theme of neurological research in Cambridge since the late 1980s.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Alemtuzumab and blood transfusion: irradiation not needed. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Remyelination varies markedly within and between lesions. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Clinical Remyelination Research (Cunniffe Group). Our research ambition is that people living with multiple sclerosis are only minimally affected by the disease. ... trial response to the COVID-19 pandemic

23 Feb 2024: However, after over a decade of research, Professor Hugh Markus and his team at the University of Cambridge working with researchers from around the world now believe their genetic breakthrough holds ... treat and a major cause of vascular dementia,

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Other inherited neurodegenerative disorders’ patient organisations. ... They support high quality research to find effective treatments and cures for all muscle-wasting conditions.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. EMA announces temporary restriction on alemtuzumab prescribing. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Association of British Neurologists advice on DMT use during COVID. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. A Trial of Bexarotene in Multiple Sclerosis [CCMR One]. ... This led us to undertake the “Cambridge Centre for Myelin Repair” One trial of bexarotene [a drug already licensed for some skin cancers] in